{"id":3936,"date":"2018-04-21T07:55:00","date_gmt":"2018-04-21T07:55:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=3936"},"modified":"2024-05-02T11:26:28","modified_gmt":"2024-05-02T09:26:28","slug":"granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/","title":{"rendered":"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis"},"content":{"rendered":"
\n

Axel Dignass<\/a> 1<\/a><\/sup>, Ayesha Akbar<\/a> 2<\/a><\/sup>, Daniel C Baumgart<\/a> 3<\/a><\/sup>, Gilles Bommelaer<\/a> 4<\/a><\/sup>, Guillaume Bouguen<\/a> 5<\/a><\/sup>, Guillaume Cadiot<\/a> 6<\/a><\/sup>, Anton Gillessen<\/a> 7<\/a><\/sup>, Jean-Charles Grimaud<\/a> 8<\/a><\/sup>, Ailsa Hart<\/a> 2<\/a><\/sup>, Syed Hoque<\/a> 9<\/a><\/sup>, Richard Makins<\/a> 10<\/a><\/sup>, Christophe Michiels<\/a> 11<\/a><\/sup>, Jacques Moreau<\/a> 12<\/a><\/sup>, Purushothaman Premchand<\/a> 13<\/a><\/sup>, Wolfgang Ramlow<\/a> 14<\/a><\/sup>, Stefan Schanz<\/a> 15<\/a><\/sup>, Sreedhar Subramanian<\/a> 16<\/a><\/sup>, Christian von Tirpitz<\/a> 17<\/a><\/sup>, Bruno Bonaz<\/a> 18<\/a><\/sup> , Scand J Gastroenterol. 2018 Apr;53(4):442-448.<\/p>\n<\/div>\n\n

\n

This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC resistant\/intolerant to IS and\/or TNF inhibitors.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/29513111\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Axel Dignass 1, Ayesha Akbar 2, Daniel C Baumgart 3, Gilles Bommelaer 4, Guillaume Bouguen 5, Guillaume Cadiot 6, Anton Gillessen 7, Jean-Charles Grimaud 8, Ailsa Hart 2, Syed Hoque 9, Richard Makins 10, Christophe Michiels 11, Jacques Moreau 12, Purushothaman Premchand 13, Wolfgang Ramlow 14, Stefan Schanz 15, Sreedhar Subramanian 16, Christian von Tirpitz 17, Bruno Bonaz 18 , Scand J Gastroenterol. 2018 Apr;53(4):442-448. This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC […]<\/p>\n","protected":false},"template":"","scientific_tags":[147,81,53,156],"class_list":["post-3936","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-long-term-outcome","scientific_tags-refractory-patients","scientific_tags-safety"],"acf":{"sc_authors":"https:\/\/pubmed.ncbi.nlm.nih.gov\/29513111\/<\/a>"},"yoast_head":"\nGranulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active\u3000ulcerative-colitis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Axel Dignass 1, Ayesha Akbar 2, Daniel C Baumgart 3, Gilles Bommelaer 4, Guillaume Bouguen 5, Guillaume Cadiot 6, Anton Gillessen 7, Jean-Charles Grimaud 8, Ailsa Hart 2, Syed Hoque 9, Richard Makins 10, Christophe Michiels 11, Jacques Moreau 12, Purushothaman Premchand 13, Wolfgang Ramlow 14, Stefan Schanz 15, Sreedhar Subramanian 16, Christian von Tirpitz 17, Bruno Bonaz 18 , Scand J Gastroenterol. 2018 Apr;53(4):442-448. This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active\u3000ulcerative-colitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:26:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/\",\"name\":\"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-04-21T07:55:00+00:00\",\"dateModified\":\"2024-05-02T09:26:28+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active\u3000ulcerative-colitis\/","og_locale":"fr_FR","og_type":"article","og_title":"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte","og_description":"Axel Dignass 1, Ayesha Akbar 2, Daniel C Baumgart 3, Gilles Bommelaer 4, Guillaume Bouguen 5, Guillaume Cadiot 6, Anton Gillessen 7, Jean-Charles Grimaud 8, Ailsa Hart 2, Syed Hoque 9, Richard Makins 10, Christophe Michiels 11, Jacques Moreau 12, Purushothaman Premchand 13, Wolfgang Ramlow 14, Stefan Schanz 15, Sreedhar Subramanian 16, Christian von Tirpitz 17, Bruno Bonaz 18 , Scand J Gastroenterol. 2018 Apr;53(4):442-448. This study confirms findings of the 12-week interim analysis and demonstrates that GMA apheresis provides a safe and beneficial long-term outcome for patients with chronic active UC […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active\u3000ulcerative-colitis\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:26:28+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/","name":"Granulocyte\/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active\u3000ulcerative colitis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-04-21T07:55:00+00:00","dateModified":"2024-05-02T09:26:28+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-monocyte-adsorptive-apheresis-for-the-treatment-of-therapy-refractory-chronic-active%e3%80%80ulcerative-colitis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/3936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=3936"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=3936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}